VESIcare is a drug that is prescribed for overactive bladder symptoms. This selection from the eMedTV archives takes an in-depth look at how this drug works and also includes dosing guidelines and information on possible side effects.
Potential side effects of VESIcare include dizziness, blurred vision, and sore throat. This eMedTV Web page also lists serious side effects that may require prompt medical attention, such as difficulty urinating, confusion, and allergic reactions.
It is possible to experience constipation while taking VESIcare. This segment from the eMedTV archives offers a more in-depth look at VESIcare and constipation, including statistics on how common it is and suggestions that may provide relief.
Dry mouth is a side effect that has been reported often with VESIcare. This portion of the eMedTV library contains more information about VESIcare and dry mouth, and provides a list of suggestions that may provide relief.
VESIcare is used for relieving overactive bladder symptoms, such as leaking accidents and urinary urgency. This eMedTV segment explores specific VESIcare uses in more detail and explains whether the drug should be used in children.
For the treatment of an overactive bladder, the recommended VESIcare dosage is 5 mg once daily. This page on the eMedTV Web site contains other VESIcare dosing guidelines and offers suggestions on how and when to take the drug.
Medicines that may interact with VESIcare include pramlintide, anticholinergics, and some antibiotics. This eMedTV page provides a detailed list of medicines that can cause negative VESIcare drug interactions and explains how they can be avoided.
Before taking VESIcare, tell your doctor if you have ulcerative colitis, glaucoma, or any allergies. This eMedTV segment includes a more detailed list of VESIcare warnings and precautions, and explains who should avoid taking the medication.
Dry eyes, difficulty passing urine, and dilated pupils are possible signs of a VESIcare overdose. This eMedTV resource describes other potential symptoms to look out for and explains the treatment options that are available for a VESIcare overdose.
Studies show that VESIcare may not be safe for use during pregnancy. This article from the eMedTV library includes more information on VESIcare and pregnancy, and describes the problems that occurred when the drug was given to pregnant animals.
Women are generally advised to avoid breastfeeding while on VESIcare. As this eMedTV page explains, since no human studies have been conducted on the link between VESIcare and breastfeeding, it is unknown whether the drug passes through breast milk.
The earliest possible date that generic VESIcare will be available is December 2015. As this eMedTV article explains, many companies currently claim to sell "generic VESIcare," but these drugs may be fake, substandard, and potentially dangerous.
| Referring Pages | Articles |
